Description
CLINICAL PHARMACOLOGY
Pharmacological studies involving laboratory animals have demonstrated Boldenone to have potent anabolic properties as well as moderate androgenic activity. In clinical trials Boldenone demonstrated a moderate to strong anabolic effect, improved appetite, increased vigor, and improved musculature and strength.
INDICATIONS
Artica Boldenone 300 is indicated as an alternate or adjunctive therapy in patients for the promotion of weight gain following: weight loss and/or muscular atrophy associated with extensive surgery, chronic infections, long term hospitali- zation, or severe trauma. For increased RBC in severe anemic patients where first-line therapy is contraindicated. For promotion of increased appetite in patients with appetite limited intake. Boldenone should be considered only as an adjunctive therapy together with other androgenic medications.